“To be or not to be in the ward”: The impact of COVID‐19 on the role of hospital‐based clinical pharmacists—A qualitative study

Abstract

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected health care systems around the world. In many hospitals and health care facilities, services and health care workers have been reorganized and restructured to meet the demands of the pandemic. The impact of the pandemic on hospital-based clinical pharmacists and their ability to deliver pharmaceutical care is currently unknown. Objective: This study aimed to explore the impact of the COVID-19 pandemic on hospital-based clinical pharmacists working in Malaysia and the implications on how clinical pharmacy is perceived as a health care service. Methods: A qualitative study was designed to meet the research objectives. Nineteen hospital-based clinical pharmacists consented and participated in one-on-one, semi-structured interviews. The interviews were transcribed and analyzed using an iterative thematic analysis approach. Results: The experiences and views of the participants were reported. Three main themes were developed: "Reassignment and other changes in clinical pharmacist roles," "Adapting clinical pharmacy services to COVID-19," and "The need for clinical pharmacists in the ward." The findings indicate that in many cases, clinical pharmacy services were fully or partially withdrawn from the ward to reduce the risk of infection and to conserve the usage of personal protective equipment. Despite this, clinical pharmacists continued to support patient care in hospitals through the use of technology. The withdrawal of clinical pharmacy services, however, raises concern that the role of clinical pharmacists is still poorly recognized. Conclusion: Clinical pharmacists in hospitals continue to support patient care despite the disruption caused by the COVID-19 pandemic. Greater support and recognition of their role is required in order to empower and enhance their ability to deliver pharmaceutical care. K E Y W O R D S clinical pharmacists, coronavirus, hospital pharmacy services Around the world, health care systems have been significantly impacted by the coronavirus disease 2019 (COVID-19) pandemic. Health care facilities have been forced to restructure their services and systems in order to prioritize infection control and manage COVID-19 patients. 1 There have been reports of health care workers being reassigned to areas deemed more essential,

What Is the Role of Pharmacists in Treating COVID-19 Patients? The Experiences and Expectations of Front Line Medical Staff

“…In many cases, the pharmaceutical care work was provided because the medical team actively invited pharmacists to participate, and pharmacists did not participate proactively. The findings are similar to a qualitative study conducted in Malaysia ( 20 ). In this study, Chinese pharmacists participated in treating COVID-19 patients through telemedicine.…”

“…One study examined strategies to strengthen the role of community pharmacists in public health ( 19 ). Another study discussed the impact of the COVID-19 pandemic on clinical pharmacists working in Malaysian hospitals and how clinical pharmacy is considered a health care service ( 20 ). These three qualitative studies introduced the non-traditional roles of pharmacists, the roles of pharmacists in public health, and the influence of pharmaceutical care under public health crises from pharmacists' perspectives.…”

Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy

“…The responses of hospital pharmacy to COVID-19 have been described in the USA, 6 9 China, 7 Australia 10 and Malaysia. 11 While many of these responses matched those employed at UHB and KCH, there were examples of differing practice.…”

“…Cheong researched the experiences of clinical pharmacists whose ward-based role was withdrawn, due to COVID-19, in Malaysia. 11 Concerns were raised about the perception of the need for a clinical pharmacy service by the wider hospital. This concern was not observed at UHB or KCH and may be due to well-established clinical pharmacy services in the UK.…”

A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future

“…In Western Australia, community pharmacists delivering vaccination services were also denied receiving any financial remuneration from the government [ 21 ]. Onozato et al pointed out the significance of administrative and political support within healthcare institutions to maintain the quality of clinical pharmacy services [ 89 ]. Bauman demonstrated that pharmacists did not get proper acknowledgement during COVID-19 like other frontline fighters.…”